|
|
|
|
| LEADER |
03018nam a2200517 4500 |
| 001 |
978-981-13-7607-8 |
| 003 |
DE-He213 |
| 005 |
20191028121213.0 |
| 007 |
cr nn 008mamaa |
| 008 |
190717s2019 si | s |||| 0|eng d |
| 020 |
|
|
|a 9789811376078
|9 978-981-13-7607-8
|
| 024 |
7 |
|
|a 10.1007/978-981-13-7607-8
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC261-271
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 072 |
|
7 |
|a MJCL
|2 thema
|
| 082 |
0 |
4 |
|a 614.5999
|2 23
|
| 245 |
1 |
0 |
|a Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
|h [electronic resource] /
|c edited by Anil K. Sharma.
|
| 250 |
|
|
|a 1st ed. 2019.
|
| 264 |
|
1 |
|a Singapore :
|b Springer Singapore :
|b Imprint: Springer,
|c 2019.
|
| 300 |
|
|
|a IX, 218 p. 115 illus., 28 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 520 |
|
|
|a This book illustrates the importance of the Natural Biometabolites, which offer a rich reservoir of candidate compounds for drug discovery in the battle against cancer. Recent research and development efforts concerning anti-cancer drugs derived from natural products have led to the identification of numerous candidate molecules that inhibit cancer cell proliferation and metastasis using a variety of mechanisms. Given its scope, the book offers a valuable resource for cancer biologists and general oncologists alike, while also benefitting research professionals in Science, Nursing, Medicine, Biochemistry, Genetics and Bioscience who wish to understand the fundamentals of prognosis and prediction in tumorigenesis. Moreover, the book provides an essential platform for understanding drug resistance mechanisms and combatting the growing menace of multidrug resistance.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Bioinformatics.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Nanotechnology.
|
| 650 |
1 |
4 |
|a Cancer Research.
|0 http://scigraph.springernature.com/things/product-market-codes/B11001
|
| 650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|0 http://scigraph.springernature.com/things/product-market-codes/B21010
|
| 650 |
2 |
4 |
|a Bioinformatics.
|0 http://scigraph.springernature.com/things/product-market-codes/L15001
|
| 650 |
2 |
4 |
|a Immunology.
|0 http://scigraph.springernature.com/things/product-market-codes/B14000
|
| 650 |
2 |
4 |
|a Nanotechnology.
|0 http://scigraph.springernature.com/things/product-market-codes/Z14000
|
| 700 |
1 |
|
|a Sharma, Anil K.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811376061
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811376085
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811376092
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-13-7607-8
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
